See beyond, decide better. AI-driven image analysis for clinical excellence.
Primary target: digital pathology AI platform
Computer Vision AI is the digital pathology AI platform from PRR.AI. It runs three image workloads: pathology AI for cancer detection and grading on whole slide images, IVF intelligence for embryo assessment, and fraud detection for medical image and report integrity. Two named products sit on it: NuGleason for Gleason grading of prostate cancer, and PathVu for whole slide image viewing and collaboration.
Every clinical output uses a human-in-the-loop design: the AI proposes, the pathologist or embryologist corrects in real time, and the correction is recorded.
01
Models return real-time insight to the clinician to support accurate grading and embryo selection.
02
Integration with pathology labs and clinics automates handling steps and reduces the manual load on the reporting queue.
03
Time saved on routine reads goes back into the cases that need a second opinion.
Each module below serves a different buyer within your organization.
For the pathology laboratory head and the reporting pathologist.
AI-driven annotation, measurement and automated diagnostics on pathology images.
A centralised platform with real-time insight and collaboration tools across the reporting team.
Models for prostate, breast and other cancer grading, delivered with heatmaps and structured scores.
AI-assisted decision support with real-time error correction by the reporting pathologist.
For the IVF clinic director and the embryology team.
Evaluates embryo quality by analysing expansion, inner cell mass and trophectoderm, against the Gardner grading system embryologists already use.
Supports the embryologist's own assessment rather than replacing it, so selection decisions stay with the clinic.
For the payer, the TPA and the hospital audit function.
Identifies reused radiology images such as ultrasound, CT and MRI using deep image comparison and perceptual hashing.
Extracts and analyses timestamps, patient IDs and scan metadata with OCR and NLP to flag inconsistencies.
Flags fabricated reports from font, layout and signature evidence, and catches duplicates filed under different IDs.
Cross-checks dates, patient IDs and timestamps against claims databases, while NLP detects suspicious narratives and inflated treatments.
Delivered work rather than licensed software, for teams without an in-house pathology AI function.
Reporting powered by AI and PRR.AI pathology experts, for laboratories without local subspecialty cover.
AI-driven tumour segmentation, biomarker analysis and cancer grading, plus model training for research and clinical trials with API integration.
The same underlying platform reads a prostate biopsy, grades a blastocyst and flags a tampered radiology record. What changes is the model and the report, not the infrastructure.
Each has its own page and its own keyword, so they do not compete with this one in search.
Gleason grading
NuGleason is a Gleason grading tool for prostate cancer from PRR.AI. It returns heatmaps, Gleason scores and standardised reports from whole slide images.
Recognised under the NCG CATCH grant programme.
NuGleason: Gleason grading AI softwareWSI viewing
PathVu is a whole slide image viewer from PRR.AI. Annotations, multiview comparison, real-time remote collaboration and AI overlays in a secure cloud viewer.
Runs in the browser. No local slide storage required.
PathVu: whole slide image viewerPRR.AI's pathology team entered the Colon Nuclei Identification and Counting (CoNIC) grand challenge, which asked entrants to segment, classify and count six nucleus types across the largest publicly available nuclei-level dataset in computational pathology.
Method write-up published on prr.ai, December 2022.
Computer Vision AI is the digital pathology AI platform from PRR.AI. It runs pathology AI for cancer detection and grading on whole slide images, IVF intelligence for embryo assessment, and fraud detection for medical image and report integrity.
The platform includes models for prostate, breast and other cancer grading. Prostate grading is delivered as the named product NuGleason, which returns heatmaps, Gleason scores and standardised reports.
The AI proposes a segmentation, a grade or a score, and the reporting pathologist corrects it in real time inside the workflow. The correction is recorded. The pathologist signs the report, not the model.
Yes. IVF intelligence applies AI-powered Gardner scoring, evaluating embryo expansion, inner cell mass and trophectoderm to support the embryologist's assessment. Embryo selection remains a clinic decision.
No. The pathology and IVF modules are decision support used with a clinician in the loop, and they are not stand-alone diagnostic devices. Regulatory status differs by module and by market, so ask us for the current position for yours.
The platform reads whole slide images and integrates with laboratory information systems and image stores.
Send a small, de-identified set from your own scanner. We will run it and walk you through the output with your pathologist.
Get started